BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+27.29%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.31B
AUM Growth
+$6.31B
(+17%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
231
New
21
Increased
88
Reduced
44
Closed
16
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$74M |
| 2 |
Charles River Laboratories
CRL
|
$42M |
| 3 |
Abbott
ABT
|
$19.7M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$18.1M |
| 5 |
Arvinas
ARVN
|
$17.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$108M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$84.8M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$84.7M |
| 4 |
Gilead Sciences
GILD
|
$35.3M |
| 5 |
Teladoc Health
TDOC
|
$32.6M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Industrials | 0.45% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.09% |
| 5 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHNG
76
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $14.2M | 0.22% |
863,922
| – | – |
|
77
Hologic
HOLX
$14.7B
| $13.7M | 0.22% |
261,779
+106,571
| +69% | +$5.56M |
|
78
Supernus Pharmaceuticals
SUPN
$2.52B
| $13.7M | 0.22% |
575,600
+159,000
| +38% | +$3.77M |
|
79
Cooper Companies
COO
$13.3B
| $13.3M | 0.21% |
166,140
+38,264
| +30% | +$3.07M |
|
|
NVRO
80
DELISTED
NEVRO CORP.
NVRO
| $12.9M | 0.2% |
109,705
-35,406
| -24% | -$4.16M |
|
81
Masimo
MASI
$7.43B
| $12.5M | 0.2% |
79,049
+10,657
| +16% | +$1.68M |
|
82
Idexx Laboratories
IDXX
$50.7B
| $12.4M | 0.2% |
47,461
+13,327
| +39% | +$3.48M |
|
83
Tandem Diabetes Care
TNDM
$834M
| $11.9M | 0.19% |
200,147
+5,411
| +3% | +$323K |
|
84
ResMed
RMD
$39.4B
| $11.7M | 0.19% |
75,810
+21,180
| +39% | +$3.28M |
|
|
GNMK
85
DELISTED
GenMark Diagnostics, Inc
GNMK
| $11.7M | 0.19% |
2,441,241
+173,989
| +8% | +$837K |
|
|
HZNP
86
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.4M | 0.18% |
315,700
-7,600
| -2% | -$275K |
|
87
Penumbra
PEN
$10.5B
| $11.3M | 0.18% |
68,855
+43,807
| +175% | +$7.2M |
|
|
OXFD
88
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $10.6M | 0.17% |
637,972
| – | – |
|
89
Quanterix
QTRX
$202M
| $10.3M | 0.16% |
435,217
+29,116
| +7% | +$688K |
|
90
10x Genomics
TXG
$1.66B
| $9.85M | 0.16% |
129,127
+29,127
| +29% | +$2.22M |
|
|
TRHC
91
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $9.82M | 0.16% |
201,635
-58
| -0% | -$2.82K |
|
92
Amgen
AMGN
$153B
| $9.73M | 0.15% |
40,350
-17,350
| -30% | -$4.18M |
|
93
LivaNova
LIVN
$3.09B
| $9.55M | 0.15% |
126,639
-144,675
| -53% | -$10.9M |
|
94
Inogen
INGN
$213M
| $9.42M | 0.15% |
137,787
+24,464
| +22% | +$1.67M |
|
95
Dentsply Sirona
XRAY
$2.77B
| $9.4M | 0.15% |
166,039
+34,221
| +26% | +$1.94M |
|
96
iRhythm Technologies
IRTC
$5.67B
| $9.3M | 0.15% |
136,563
-47,856
| -26% | -$3.26M |
|
|
SWAV
97
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $9.26M | 0.15% |
210,758
+109,400
| +108% | +$4.8M |
|
|
AMED
98
DELISTED
Amedisys
AMED
| $8.91M | 0.14% |
53,365
-122,293
| -70% | -$20.4M |
|
99
Cidara Therapeutics
CDTX
$1.61B
| $8.81M | 0.14% |
114,764
| – | – |
|
100
Guardant Health
GH
$8.11B
| $8.61M | 0.14% |
110,136
+15,375
| +16% | +$1.2M |
|